Incorporating molecular markers in standard prognostic models for DLBCL patients using real-world data
Overall survival (OS) in advanced non-small cell lung cancer (aNSCLC) patients treated with frontline chemotherapy or immunotherapy by comorbidity: A real-world data (RWD) collaboration
Trends in immunotherapy use in patients with advanced non-small cell lung cancer (aNSCLC) patients: Analysis of real-world data
Assessing real-world clinical response in patients with multiple myeloma (MM): A survey of the literature
Disparities in clinical characteristics and treatment of multiple myeloma in African American patients.
KarMMa-RW: A study of real-world treatment patterns in heavily pretreated patients with relapsed and refractory multiple myeloma (RRMM) and comparison of outcomes to KarMMa.
Real-world characterization of advanced/metastatic non-small cell lung cancer (aNSCLC) patients (pts) with rapid disease progression (RDP)
The unforeseen business and medical consequences of EHR data collection for a real-world data multiple myeloma registry
Profiling for microsatellite instability (MSI) and mismatch repair (MMR) among patients with colon cancer in real world settings
